At this time, posts about JW Jungwoo Pharmaceutical are rapidly increasing on portals and stock communities, with foreign investors tentatively reported to have net purchased 8,471 shares today. JW Jungwoo Pharmaceutical is known as a leading pharmaceutical company in the industry, famous for its intravenous solutions.

As of 11:30 AM on the 19th, JW Jungwoo Pharmaceutical's stock price is 33,350 KRW, down 6.19% from the previous day, with a trading volume of 449,198 shares, which is about 17.03% of the 5-day average trading volume. On May 15th, JW Jungwoo Pharmaceutical was a market issue with the headline "Expansion of price increase due to COVID-19 resurgence."

In addition to JW Jungwoo Pharmaceutical, posts by investors are also surging for ELK (094190), S-Oil (010950), and Toptec (108230).

※Source: AI Investment Assistant AI Rassi

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing